Research Program: Cancer Outcomes and Survivorship
Assistant Professor, Department of Medicine, Division of Hematology, Oncology and Transplantation

blaes004@umn.edu
612-626-8138 — office
Preferred method of contact: e-mail

Dr. Blaes's clinical profile
(University of Minnesota Physicians Web site)

Dr. Anne Blaes is an assistant professor in the Division of Hematology, Oncology and Transplantation. She graduated from the University of Notre Dame in 1998 with a B.S. in biological sciences, and then received her M.D. degree from Loyola University Chicago, Stritch School of Medicine in 2002. She performed her residency at the University of Minnesota, where she was named the Resident Teacher of the Year, and also received The Gold Foundation Humanism and Excellence in Teaching Award for her outstanding contributions as a resident role model. She served as chief resident in internal medicine 2005-2006 and then subsequently completed her hematology and oncology fellowship at the University of Minnesota. She also obtained a masters of science in clinical research from the School of Public Health, University of Minnesota, during her fellowship.

Research Interests

Dr. Blaes joined the faculty at the University of Minnesota in 2009. She has a special interest in medical education with a clinical interest in the management of hematologic malignancies, lymphoma, and breast cancer. She has recently started seeing patients in the Long-Term Follow-Up Clinic for Adult Cancer Survivors. Her research interests include quality of life, cardiac complications of chemotherapy, and the late effects of cancer therapy in cancer survivors.

Selected Publications

Blaes A, Morrison V, Peterson B, et al. Rituximab therapy is effective for post-solid organ transplant lymphoproliferative disorders (PTLD): Results of a Phase II Trial. Cancer. 2005 Oct; 104(8):1661-7.

Blaes AH, Santa-Cruz KS, Lee CK, Hui SK, Peterson BA. Necrotizing Leukoencephalopathy Following CHOP Chemotherapy. Leukemia Research 2008; 32(10): 1611-1614.

Blaes AH, Cioc AM, Froelich JW, Peterson BA, Dunitz JM. Positron Emission Tomography Scanning in the Setting of Post-Transplant Lymphoproliferative Disorders. Clinical Transplantation 2008 (epub).

Blaes AH, Cavert W, Morrison V. Malassezia: Is it a pulmonary pathogen in the stem cell transplant population? Transplant Infectious Disease 2009 Aug;11(4):313-7.

Blaes AH, Morrison VA: Non-Hodgkin's lymphoma in the elderly, in Practical Geriatric Oncology. Cohen H, Hurria A (ed), Cambridge University Press 2009.

Blaes AH, Cao Q, Wagner JE, Young JH, Weisdorf DJ, Brunstein CG. Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after anti-thymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation. BBMT 2009 (in press).

Blaes AH, Peterson BA,Yee D, Virnig B. Do ACE-I protect against the development of doxorubicin cardiac toxicity?  American Society of Clinical Oncology. Orlando, Florida 2009. Abstract ID: 6623 (35087).

Blaes AH, Ma L, Peterson BA. Quality of Life in Non-Hodgkin Lymphoma: A Comparison Between Survivors of Indolent and Aggressive Disease. American Society of Hematology. New Orleans, LA 2009. Abstract 2494 (19720)